Implementation and operational research: Evolution of antiretroviral therapy services for HIV-infected pregnant women in Cape Town, South Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 69, Issue 2, 2015, Pages e57-e65

  Myer, Landon ^a   Phillips, Tamsin ^a   Manuelli, Victoria ^b   McIntyre, James ^a,c   Bekker, Linda Gail ^a   Abrams, Elaine J ^d,e  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ANOVA HEALTH INSTITUTE   (South Africa)

^d Mailman School of Public Health ^*  (United States)

^e Columbia University ^*  (United States)

Author keywords

antenatal care; antiretroviral therapy; mother to child transmission; point of care CD4; pregnancy; service integration; South Africa

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; FEMALE; HEALTH CARE DELIVERY; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; POINT OF CARE TESTING; PREGNANT WOMAN; PRENATAL CARE; PRIORITY JOURNAL; SOUTH AFRICA;

EID: 84929938110     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000584     Document Type: Article

References (42)

1. Abrams EJ, Myer L. Can we achieve an AIDS-free generation? Perspectives on the global campaign to eliminate new pediatric HIV infections. J Acquir Immune Defic Syndr. 2013;63(suppl 2):S208-S212.
2. Barron P, Pillay Y, Doherty T, et al. Eliminating mother-to-child HIV transmission in South Africa. Bull World Health Organ. 2013;91:70-74.
3. Chi BH, Stringer JS, Moodley D. Antiretroviral drug regimens to prevent mother-to-child transmission of HIV: A review of scientific, program, and policy advances for sub-Saharan Africa. Curr Hiv/AIDS Rep. 2013;10: 124-133.
4. McIntyre J. Use of antiretrovirals during pregnancy and breastfeeding in low-income and middle-income countries. Curr Opin HIV AIDS. 2010;5: 48-53.
5. World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Geneva, Switzerland: WHO; 2013.
6. Gourlay A, Birdthistle I, Mburu G, et al. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: A systematic review. J Int AIDS Soc. 2013;16:18588.
7. UNICEF. Towards and AIDS-Free Generation: Children & AIDS, 6th Stocktaking Report. New York, NY: UNICEF; 2013.
8. Sprague C, Chersich MF, Black V. Health system weaknesses constrain access to PMTCT and maternal HIV services in South Africa: A qualitative enquiry. AIDS Res Ther. 2011;8:10.
9. Ferguson L, Grant AD, Watson-Jones D, et al. Linking women who test HIVpositive in pregnancy-related services to long-term HIV care and treatment services: A systematic review. Trop Med Int Health. 2012;17:564-580.
10. Stinson K, Jennings K, Myer L. Integration of antiretroviral therapy services into antenatal care increases treatment initiation during pregnancy: A cohort study. PLoS One. 2013;8:e63328.
11. Watson-Jones D, Balira R, Ross DA, et al. Missed opportunities: poor linkage into ongoing care for HIV-positive pregnant women in Mwanza, Tanzania. PLoS One. 2012;7:e40091.
12. Msellati P. Improving mothers' access to PMTCT programs in West Africa: A public health perspective. Soc Sci Med. 2009;69:807-812.
13. Kim MH, Ahmed S, Buck WC, et al. The Tingathe programme: A pilot intervention using community health workers to create a continuum of care in the prevention of mother to child transmission of HIV cascade of services in Malawi. J Int AIDS Soc. 2012;15(suppl 2):17389.
14. Killam WP, Tambatamba BC, Chintu N, et al. Antiretroviral therapy in antenatal care to increase treatment initiation in HIV-infected pregnant women: A stepped-wedge evaluation. AIDS. 2010;24:85-91.
15. Suthar AB, Hoos D, Beqiri A, et al. Integrating antiretroviral therapy into antenatal care and maternal and child health settings: A systematic review and meta-analysis. Bull World Health Organ. 2013;91:46-56.
16. van der Merwe K, Chersich MF, Technau K, et al. Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa. J Acquir Immune Defic Syndr. 2006;43:577-581.
17. Tudor Car L, Van Velthoven MH, Brusamento S, et al. Integrating prevention of mother-to-child HIV transmission programs to improve uptake: A systematic review. PLoS One. 2012;7:e35268.
18. World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Towards Universal Access. Geneva, Switzerland: WHO; 2006.
19. World Health Organization. Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants: Recommendations for a Public Health Approach. Geneva, Switzerland: WHO; 2010.
20. Weigel R, Hosseinipour MC, Feldacker C, et al. Ensuring HIV-infected pregnant women start antiretroviral treatment: an operational cohort study from Lilongwe, Malawi. Trop Med Int Health. 2012;17:751-759.
21. Chen JY, Ogwu AC, Svab P, et al. Antiretroviral treatment initiation among HIV-infected pregnant women with low CD4 + cell counts in Gaborone, Botswana. J Acquir Immune Defic Syndr. 2010;54:102-106.
22. De Schacht C, Lucas C, Sitoe N, et al. Point of care CD4 testing leads to increased uptake of antiretroviral therapy among pregnant women in Gaza Province, Mozambique. Abstract THPE079. Paper presented at: 19th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington, March 5-8, 2012.
23. Mnyani CN, McIntyre JA, Myer L. The reliability of point-of-care CD4 testing in identifying HIV-infected pregnant women eligible for antiretroviral therapy. J Acquir Immune Defic Syndr. 2012;60:260-264.
24. Schouten EJ, Jahn A, Midiani D, et al. Prevention of mother-to-child transmission of HIV and the health-related millennium development goals: time for a public health approach. Lancet. 2011;378:282-284.
25. Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: A review of the evidence for the Option B+ approach. Curr Opin HIV AIDS. 2013;8:474-489.
26. Shaffer N, Abrams EJ, Becquet R. Option B+ for prevention of motherto-child transmission of HIV in resource-constrained settings: great promise but some early caution. AIDS. 2014;28:599-601.
27. Bekker LG, Myer L, Orrell C, et al. Rapid scale-up of a communitybased HIV treatment service: programme performance over 3 consecutive years in Gugulethu, South Africa. S Afr Med J. 2006;96:315-320.
28. Myer L, Daskilewicz K, McIntyre J, et al. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women. J Int AIDS Soc. 2013;16:18649.
29. Myer L, Zulliger R, Black S, et al. Pilot programme for the rapid initiation of antiretroviral therapy in pregnancy in Cape Town, South Africa. AIDS Care. 2012;24:986-992.
30. Zulliger R, Black S, Holtgrave DR, et al. Cost-effectiveness of a package of interventions for expedited antiretroviral therapy initiation during pregnancy in Cape Town, South Africa. AIDS Behav. 2014;18:697-705.
31. Provincial Government of the Western Cape. PMTCT Clinical Guidelines Update, May 2013. Cape Town, South Africa: PGWC; 2013.
32. Cuzick JA. Wilcoxon-type test for trend. Stat Med. 1985;4:87-90.
33. Stinson K, Boulle A, Coetzee D, et al. Initiation of highly active antiretroviral therapy among pregnant women in Cape Town, South Africa. Trop Med Int Health. 2010;15:825-832.
34. Hussain A, Moodley D, Naidoo S, et al. Pregnant women's access to PMTCT and ART services in South Africa and implications for universal antiretroviral treatment. PLoS One. 2011;6:e27907.
35. Muchedzi A, Chandisarewa W, Keatinge J, et al. Factors associated with access to HIV care and treatment in a prevention of mother to child transmission programme in urban Zimbabwe. J Int AIDS Soc. 2010;13:38.
36. Chibwesha CJ, Giganti MJ, Putta N, et al. Optimal time on HAART for prevention of mother-to-child transmission of HIV. J Acquir Immune Defic Syndr. 2011;58:224-228.
37. Townsend CL, Byrne L, Cortina-Borja M, et al. Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS. 2014;28:1049-1057.
38. Centers for Disease Control and Prevention (CDC). Impact of an innovative approach to prevent mother-to-child transmission of HIV-Malawi, July 2011-September 2012. MMWR Morb Mortal Wkly Rep. 2013;62:148-151.
39. Kuhn L, Aldrovandi GM, Sinkala M, et al. Potential impact of new WHO criteria for antiretroviral treatment for prevention of mother-to-child HIV transmission. AIDS. 2010;24:1374-1377.
40. Myer L. Initiating antiretroviral therapy in pregnancy: The importance of timing. J Acquir Immune Defic Syndr. 2011;58:125-126.
41. Tenthani L, Haas AD, Tweya H, et al; Ministry of Health in Malawi and IeDEA Southern Africa. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ("Option B+") in Malawi. AIDS. 2014;28:589-598.
42. Coutsoudis A, Goga A, Desmond C, et al. Is Option B+ the best choice? Lancet. 2013;381:269-271.